323 related articles for article (PubMed ID: 8675091)
41. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
[TBL] [Abstract][Full Text] [Related]
42. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
Broomé U; Löfberg R; Veress B; Eriksson LS
Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
[TBL] [Abstract][Full Text] [Related]
43. Ulcerative colitis-linked antineutrophil cytoplasmic antibody in the cotton-top tamarin model of colitis.
Targan SR; Landers CJ; King NW; Podolsky DJ; Shanahan F
Gastroenterology; 1992 May; 102(5):1493-8. PubMed ID: 1568559
[TBL] [Abstract][Full Text] [Related]
44. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
45. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
46. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
[No Abstract] [Full Text] [Related]
47. IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.
Farahmand F; Ahmadi M; Khodadad A; Najafi M; Fallahi G; Motamed F; Movahedi M; Aghamohammadi A; Rezaei N; Javaherizadeh H
Clin Exp Hepatol; 2019 Nov; 5(4):285-288. PubMed ID: 31893239
[TBL] [Abstract][Full Text] [Related]
48. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
[TBL] [Abstract][Full Text] [Related]
49. Circulating CD4+CD25+ regulatory T cells in the pathobiology of ulcerative colitis and concurrent primary sclerosing cholangitis.
Kekilli M; Tunc B; Beyazit Y; Kurt M; Onal IK; Ulker A; Haznedaroglu IC
Dig Dis Sci; 2013 May; 58(5):1250-5. PubMed ID: 23306841
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
[TBL] [Abstract][Full Text] [Related]
51. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
52. High potential to reverse the inhibition of myeloperoxidase by ceruloplasmin of anti-myeloperoxidase autoantibodies of IgG3 subclass.
Xu PC; Chen M; Zhao MH
Autoimmunity; 2012 May; 45(3):218-25. PubMed ID: 21875381
[TBL] [Abstract][Full Text] [Related]
53. Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Venkatesh PG; Choudhary M; Shen B; Kiran RP
J Crohns Colitis; 2013 Mar; 7(2):e35-41. PubMed ID: 22554774
[TBL] [Abstract][Full Text] [Related]
54. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
55. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
[TBL] [Abstract][Full Text] [Related]
56. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.
Saxon A; Shanahan F; Landers C; Ganz T; Targan S
J Allergy Clin Immunol; 1990 Aug; 86(2):202-10. PubMed ID: 2200820
[TBL] [Abstract][Full Text] [Related]
57. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
58. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells.
Sakamaki S; Takayanagi N; Yoshizaki N; Hayashi S; Takayama T; Kato J; Kogawa K; Yamauchi N; Takemoto N; Nobuoka A; Ayabe T; Kohgo Y; Niitsu Y
Gut; 2000 Aug; 47(2):236-41. PubMed ID: 10896915
[TBL] [Abstract][Full Text] [Related]
59. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
